SC
MDLN

Sculptor Capital’s Medline Inc MDLN Stock Holding History

Sculptor Capital’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2M Sell
230,000
-270,000
-54% -$11.9M 0.11% 135
2025
Q4 		$21M Buy
+500,000
New +$21.1M 0.22% 102

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Sculptor Capital's MDLN Position: Q1 2026 in Review

Sculptor Capital reduced its Medline Inc (MDLN) stake by 54% in Q1 2026, selling an estimated $11.9M and leaving 230,000 shares worth $10.2M. The position accounts for 0.11% of the portfolio, ranked #135.

Sculptor Capital first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. The position peaked at $21M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Sculptor Capital held 230,000 shares of Medline Inc worth $10.2M as of Q1 2026.
  • Sculptor Capital sold 270,000 Medline Inc shares in Q1 2026, an estimated $11.9M.
  • Medline Inc made up 0.11% of Sculptor Capital's portfolio in Q1 2026, its #135 holding.
  • Sculptor Capital first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • Sculptor Capital's Medline Inc position peaked at $21M in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Sculptor Capital's 13F filing for Q1 2026, filed 15 May 2026.